Announce Date | 05/01/2025 |
EPS Normalized Actual | $3.95 (Beat by $0.03) |
EPS GAAP Actual | $3.95 (Beat by $0.03) |
Revenue Actual | $8.112B |
Revenue Surprise | Beat by $8112M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $4.33778 |
EPS GAAP Estimate | $4.33778 |
Revenue Estimate | $8.944980081B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 22.54 | 21.1 | 21.54902 | 23.27082 | 1 |
Dec 2028 | 22.49 | 21.15 | 21.87938 | 23.38291 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.53 | 3.53 | 8.112B | 0.15% | 8112M |
FQ4 2024 (Dec 2024) | 3.6 | 3.6 | 8.282B | -53.74% | 8282M |
FQ3 2024 (Sep 2024) | 3.24 | 3.24 | 8.356B | 2.41% | 8356M |
FQ2 2024 (Jun 2024) | 3.46 | 3.46 | 8.267B | -51.45% | 8267M |
FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 8.1B | -1.15% | 8100M |
FQ4 2023 (Dec 2023) | 0.0032 | 0.0032 | 12.733B | 37.96% | 12733M |
FQ3 2023 (Sep 2023) | 3.21 | 3.21 | 8.155B | -7.87% | 8155M |
FQ2 2023 (Jun 2023) | 0.0032 | 0.0032 | 12.52B | 32.45% | 12520M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
4.33778
Consensus Revenue Estimates
8.944980081B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 5.2116 | -- | 5.2116 | 5.2116 | 8 |
FQ3 2027 (Jul 2027) | 5.0449 | -- | 5.0449 | 5.0449 | 5 |
FQ2 2027 (Jun 2027) | 5.0449 | -- | 4.95075 | 5.20614 | 5 |
FQ1 2027 (Mar 2027) | 4.853 | -- | 4.76243 | 5.00811 | 5 |
FQ4 2026 (Oct 2026) | 4.78537 | -- | 4.78537 | 4.78537 | 7 |
FQ3 2026 (Jul 2026) | 4.63836 | -- | 4.63836 | 4.63836 | 4 |
FQ2 2026 (Jun 2026) | 4.61853 | -- | 4.53234 | 4.76615 | 8 |
FQ1 2026 (Mar 2026) | 4.44548 | 20.59 | 4.36252 | 4.58757 | 8 |
FQ4 2025 (Oct 2025) | 4.36407 | 17.51 | 4.36407 | 4.36407 | 7 |
FQ3 2025 (Sep 2025) | 4.33778 | 25.31 | 4.25683 | 4.47642 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 9.32B | -- | 9.32B | 9.32B | 4 |
FQ3 2027 (Jul 2027) | 9.23B | -- | 9.23B | 9.23B | 6 |
FQ2 2027 (Jun 2027) | 9.32B | -- | 9.19B | 9.55B | 5 |
FQ1 2027 (Mar 2027) | 9.23B | -- | 9.1B | 9.46B | 4 |
FQ4 2026 (Oct 2026) | 9.71B | -- | 9.71B | 9.71B | 4 |
FQ3 2026 (Jul 2026) | 9.51B | -- | 9.51B | 9.51B | 6 |
FQ2 2026 (Jun 2026) | 9.4B | -- | 9.27B | 9.63B | 5 |
FQ1 2026 (Mar 2026) | 9.18B | 11.67 | 9.05B | 9.41B | 4 |
FQ4 2025 (Oct 2025) | 9.14B | 9.4 | 9.14B | 9.14B | 3 |
FQ3 2025 (Sep 2025) | 8.94B | 6.58 | 8.82B | 9.16B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.53 | 3.53 | 100% | |
FQ4 2024 (Dec 2024) | 3.6 | 3.6 | 100% | |
FQ3 2024 (Sep 2024) | 3.24 | 3.24 | 100% | |
FQ2 2024 (Jun 2024) | 3.46 | 3.46 | 100% | |
FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 100% | |
FQ4 2023 (Dec 2023) | 0.0032 | 0.0032 | 100% | |
FQ3 2023 (Sep 2023) | 3.21 | 3.21 | 100% | |
FQ2 2023 (Jun 2023) | 0.0032 | 0.0032 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $8.11B | $8112M | 100% |
FQ4 2024 (Dec 2024) | $0B | $8.28B | $8282M | 100% |
FQ3 2024 (Sep 2024) | $0B | $8.36B | $8356M | 100% |
FQ2 2024 (Jun 2024) | $0B | $8.27B | $8267M | 100% |
FQ1 2024 (Mar 2024) | $0B | $8.1B | $8100M | 100% |
FQ4 2023 (Dec 2023) | $0B | $12.73B | $12733M | 100% |
FQ3 2023 (Sep 2023) | $0B | $8.16B | $8155M | 100% |
FQ2 2023 (Jun 2023) | $0B | $12.52B | $12520M | 100% |